Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-6-6
pubmed:abstractText
To evaluate feasibility and safety of MGuard based percutaneous coronary interventions (PCI) in vein grafts (VG) and native coronaries (NC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1878-0938
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
138-46
pubmed:meshHeading
pubmed-meshheading:21640931-Aged, pubmed-meshheading:21640931-Angioplasty, Balloon, Coronary, pubmed-meshheading:21640931-Anticoagulants, pubmed-meshheading:21640931-Biological Markers, pubmed-meshheading:21640931-Coronary Angiography, pubmed-meshheading:21640931-Coronary Artery Bypass, pubmed-meshheading:21640931-Coronary Artery Disease, pubmed-meshheading:21640931-Creatine Kinase, pubmed-meshheading:21640931-Electrocardiography, pubmed-meshheading:21640931-Embolism, pubmed-meshheading:21640931-Feasibility Studies, pubmed-meshheading:21640931-Female, pubmed-meshheading:21640931-Germany, pubmed-meshheading:21640931-Graft Occlusion, Vascular, pubmed-meshheading:21640931-Humans, pubmed-meshheading:21640931-Kaplan-Meier Estimate, pubmed-meshheading:21640931-Male, pubmed-meshheading:21640931-Middle Aged, pubmed-meshheading:21640931-Myocardial Infarction, pubmed-meshheading:21640931-Platelet Aggregation Inhibitors, pubmed-meshheading:21640931-Prospective Studies, pubmed-meshheading:21640931-Prosthesis Design, pubmed-meshheading:21640931-Stents, pubmed-meshheading:21640931-Thrombosis, pubmed-meshheading:21640931-Time Factors, pubmed-meshheading:21640931-Treatment Outcome
pubmed:articleTitle
Coronary stenting with MGuard: extended follow-up of first human trial.
pubmed:affiliation
Department of Cardiology, Helios Heart Center, Siegburg, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study